Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Lecanemab to Serve as Gamechanger in Science, Treatments Set to Start by Year-End: Biogen Japan Chief
September 21, 2023
-
REGULATORY Pharma Groups Stand in Unity to Push Reward for Innovation, Price Maintenance
September 21, 2023
-
REGULATORY MHLW Proposes Curbing Entries of Generic Makers That Threaten Stable Supplies
September 20, 2023
-
REGULATORY Japan to End Use of Original COVID Vaccine, Previous Omicron Jabs
September 20, 2023
-
ORGANIZATION JPMA Embarking on Creation of One-Stop Platform for Rare Disease Trial Info
September 19, 2023
-
REGULATORY Japan to Require Out-of-Pocket Cost for COVID Drugs from October
September 19, 2023
-
REGULATORY New Health Minister Vows to Put Public Needs First in 2024 Drug Pricing Reform
September 15, 2023
-
REGULATORY Japan to Basically Drop Japanese PI Requirement before Global Clinical Trials
September 14, 2023
-
REGULATORY Chuikyo Mixed on Expanding Range of CEA Price Adjustments for Pricey Meds
September 14, 2023
-
REGULATORY Keizo Takemi Tapped as New Health Minister in Cabinet Reshuffle
September 14, 2023
-
REGULATORY Japan’s Envisaged IP Tax Relief Likely to Cover Drug Sales, METI Eyes FY2024 Rollout
September 13, 2023
-
REGULATORY Moderna’s Omicron XBB.1.5 Vaccine Snags Japan Approval
September 12, 2023
-
REGULATORY New MHLW Drug Review Chief Vows to Make Japan Attractive Place for Clinical Trials, Watching Debate on Japanese PI
September 12, 2023
-
BUSINESS Sumitomo to Ramp Up Regenerative, Cell Therapy Biz to Counter Latuda Patent Cliff
September 11, 2023
-
BUSINESS After Idorsia Deal, Sosei Pivoting to High-Profit Model with In-House Sales System
September 8, 2023
-
BUSINESS Astellas Drops IRA Lawsuit after Xtandi Avoids 1st Drug List
September 8, 2023
-
ORGANIZATION Single-Wholesaler Model Has No Merits for Hospitals: Hyogo Doctors Group
September 7, 2023
-
REGULATORY Japan Eyes AI-Driven Drug Discovery Project for Cancer, Intractable Diseases
September 7, 2023
-
BUSINESS Osaka Court Bars Sawai’s Teribone Generic over Manufacturing Patents
September 6, 2023
-
BUSINESS Santen to Run Voluntary Redundancy Program Targeting Age 50 and Up
September 5, 2023
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…